A new drug pricing system reform proposal in Japan
A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.
Latest news
BGI hit with $8m damages bill in patent dispute with Illumina
02-12-2021
Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.
Regions
Sectors
- BGI hit with $8m damages bill in patent dispute with Illumina
- Moderna exposed after losing COVID-19 vaccine patent decision
- Fed Circuit split decision denies Biogen’s bid to revive MS drug patent
- Omicron variant delays COVID-19 IP waiver debate
- Biofrontera settles patent dispute with Dusa over skin treatment